⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2932014 | 1.00 | — | — | |
| SCHEMBL28034175 | 0.97 | OR51E2 (0.38) | — | |
| SCHEMBL3505065 | 0.78 | — | — | |
| SCHEMBL3505066 | 0.78 | — | — | |
| SCHEMBL8943586 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL34656 | 0.77 | — | — | |
| SCHEMBL360177 | 0.77 | — | — | |
| SCHEMBL34657 | 0.77 | — | — | |
| SCHEMBL9225657 | 0.77 | — | — | |
| SCHEMBL8181223 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1844022-B1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI SCIENCE CO LTD (KR) | 2013-08-14 | — | — | EP | claimed |
| JP-2008525522-A | — | — | 2008-07-17 | — | — | JP | claimed |
| US-20080009509-A1 | Quinazoline Derivatives For Inhibiting Cancer Cell Growth And Method For The Preparation Thereof | HANMI PHARM CO., LTD (KR) | 2008-01-10 | — | — | US | claimed |
| EP-1844022-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | Hanmi Pharm. Co., Ltd. (KR) | 2007-10-17 | — | — | EP | claimed |
| WO-2006071017-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM. CO., LTD. (KR) | 2006-07-06 | — | — | WO | claimed |
| US-9345997-B2 | Active polymeric filters | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2016-05-24 | — | — | US | disclosed |
| US-20130317178-A1 | ACTIVE POLYMERIC FILTERS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-11-28 | — | — | US | disclosed |
| US-8524920-B2 | Active polymeric filters | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-09-03 | — | — | US | disclosed |
| US-8524919-B2 | Active polymeric filters | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-09-03 | — | — | US | disclosed |
| EP-1844022-B1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI SCIENCE CO LTD (KR) | 2013-08-14 | — | — | EP | disclosed |
| WO-2013058736-A1 | ACTIVE POLYMERIC FILTERS COMPRISING PENDANT DIOXIRANES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-04-25 | — | — | WO | disclosed |
| US-20130092638-A1 | ACTIVE POLYMERIC FILTERS | CRESTLINE DIRECT FINANCE, L.P. | 2013-04-18 | — | — | US | disclosed |
| EP-1844022-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | Hanmi Pharm. Co., Ltd. (KR) | 2007-10-17 | — | — | EP | disclosed |
| US-7087797-B2 | Continuous hydroformylation process | DSM IP ASSETS B.V. (NL) | 2006-08-08 | — | — | US | disclosed |
| WO-2006071017-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM. CO., LTD. (KR) | 2006-07-06 | — | — | WO | disclosed |
| US-20040152924-A1 | Continuous hydroformylation process | DSM I.P. ASSETS B.V. (NL) | 2004-08-05 | — | — | US | disclosed |
| EP-1392633-A1 | CONTINUOUS HYDROFORMYLATION PROCESS | DSM IP Assets B.V. (NL) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002083613-A1 | CONTINUOUS HYDROFORMYLATION PROCESS | DSM IP ASSETS B.V. (NL) | 2002-10-24 | — | — | WO | disclosed |
| EP-1249439-A1 | Continuous hydroformylation process | DSM N.V. (NL) | 2002-10-16 | — | — | EP | disclosed |
| EP-1249441-A1 | Continuous hydroformylation process | DSM N.V. (NL) | 2002-10-16 | — | — | EP | disclosed |